Skip to main content

Table 1 Patient characteristics at baseline

From: Economic evaluation of a behavioral intervention versus brief advice for substance use treatment in pregnant women: results from a randomized controlled trial

Characteristics

Overall (n = 112)

Brief Advice (n = 60)

MET-CBT (n = 52)

Age (in years)

25.1 ± 6.1

25.4 ± 5.8

24.8 ± 6.4

Race

 White

36 (32.4%)

19 (32.2%)

17 (32.7%)

 Black

59 (53.2%)

31 (52.5%)

28 (53.8%)

 Other

16 (14.4%)

9 (15.3%)

7 (13.5%)

Hispanic ethnicity

 Yes

29 (25.9%)

17 (28.3%)

12 (23.1%)

 No

83 (74.1%)

43 (71.7%)

40 (76.9%)

Education (in years)

  < 12

39 (35.1%)

20 (33.3%)

19 (37.3%)

 12

42 (37.8%)

20 (33.3%)

22 (43.1%)

 13–15

25 (22.5%)

16 (26.7%)

9 (17.7%)

  ≥ 16

5 (4.5%)

4 (6.7%)

1 (2.0%)

Type of insurance/payer

 Medicaid

106 (94.6%)

54 (90.0%)

52 (100.0%)

 Other

6 (5.4%)

6 (10.0%)

0 (0.0%)

Parity

 0

42 (37.5%)

22 (36.7%)

20 (38.5%)

 1

34 (30.4%)

21 (35.0%)

13 (25.0%)

  ≥ 2

36 (32.1%)

17 (28.3%)

19 (36.5%)

Gestation age at time of enrollment, weeks

20.1 ± 7.2

20.3 ± 7.3

20.0 ± 7.2

Primary drug

 Alcohol

36 (32.1%)

18 (30.0%)

18 (34.6%)

 Cocaine

23 (20.5%)

12 (20.0%)

11 (21.2%)

 Marijuana

44 (39.3%)

24 (40.0%)

20 (38.5%)

 Other

9 (8.0%)

6 (10.0%)

3 (5.8%)

Ever regularly used more than one substance

 Yes

57 (51.8%)

33 (56.9%)

24 (46.2%)

 No

53 (48.2%)

25 (43.1%)

28 (53.8%)

MINI drug/alcohol abuse/dependence

 Yes

36 (32.1%)

23 (38.3%)

13 (25.0%)

 No

76 (67.9%)

37 (61.7%)

39 (75.0%)

  1. MET-CBT motivational enhancement therapy with cognitive behavioral therapy, MINI Mini-International Neuropsychiatric Interview. Statistics were reported as n (%) or mean ± standard deviation. Percentages may not add up to 100% due to rounding